Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease
- PMID: 1624158
- PMCID: PMC1379334
- DOI: 10.1136/gut.33.6.773
Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease
Abstract
Cytokines released from activated mononuclear leukocytes are involved in triggering the acute phase response and many of the inflammatory manifestations of ulcerative colitis and Crohn's disease. The ability of circulating monocytes from patients with ulcerative colitis and Crohn's disease to generate the cytokines interleukin 1 beta (IL 1 beta) and tumour necrosis factor alpha (TNF alpha), both spontaneously and in response to stimulation by lipopolysaccharide, was compared. IL 1 beta generation in response to lipopolysaccharide was significantly higher in Crohn's disease than in ulcerative colitis and normal controls, with a dramatic increase in patients with active disease. There was a significant reduction in lipopolysaccharide stimulated TNF alpha generation in ulcerative colitis patients compared with Crohn's disease and normal control subjects. IL 1 beta and TNF alpha release correlated significantly with serum C reactive protein and serum alpha 1 acid glycoprotein in Crohn's disease. The ability of conditioned medium from monocytes in Crohn's disease to enhance release of alpha 1 acid glycoprotein from the liver cell line HepG2 in culture was assessed. There was a significant positive correlation between TNF alpha and IL 1 beta presence in the supernatant and alpha 1 acid glycoprotein production. The differences in the cytokine profile in patients with Crohn's disease compared with ulcerative colitis suggest an intrinsic difference in the ability to produce cytokines in patients with these two forms of inflammatory bowel disease, and may explain features such as the enhanced ability to generate a brisk C reactive protein response in Crohn's disease.
Similar articles
-
Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.Gut. 1994 Jan;35(1):77-83. doi: 10.1136/gut.35.1.77. Gut. 1994. PMID: 8307455 Free PMC article.
-
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.Clin Exp Immunol. 1993 Oct;94(1):174-81. doi: 10.1111/j.1365-2249.1993.tb05997.x. Clin Exp Immunol. 1993. PMID: 8403503 Free PMC article.
-
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.Gut. 2002 Feb;50(2):196-200. doi: 10.1136/gut.50.2.196. Gut. 2002. PMID: 11788559 Free PMC article. Clinical Trial.
-
[Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].Nihon Rinsho. 2002 Mar;60(3):531-8. Nihon Rinsho. 2002. PMID: 11904969 Review. Japanese.
-
Inflammatory mediators in chronic inflammatory bowel diseases.Klin Wochenschr. 1991 Dec 15;69(21-23):981-7. doi: 10.1007/BF01645143. Klin Wochenschr. 1991. PMID: 1798295 Review.
Cited by
-
In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.Gut. 1997 Apr;40(4):475-80. doi: 10.1136/gut.40.4.475. Gut. 1997. PMID: 9176074 Free PMC article.
-
Significance of systemic endotoxaemia in inflammatory bowel disease.Gut. 1995 Jun;36(6):897-901. doi: 10.1136/gut.36.6.897. Gut. 1995. PMID: 7615280 Free PMC article.
-
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD.Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):531-543. doi: 10.1038/s41575-019-0172-4. Epub 2019 Jul 16. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31312042 Review.
-
Genetic markers in clinically well defined patients with ulcerative colitis (UC).Clin Exp Immunol. 1999 Feb;115(2):294-300. doi: 10.1046/j.1365-2249.1999.00797.x. Clin Exp Immunol. 1999. PMID: 9933456 Free PMC article.
-
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease.J Crohns Colitis. 2014 Nov;8(11):1539-47. doi: 10.1016/j.crohns.2014.06.013. Epub 2014 Jul 19. J Crohns Colitis. 2014. PMID: 25052346 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials